Nimesulide 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablet in PCD pharma franchise in Hyderabad

Nimesulide 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablet in pharmaceutical manufacturing company in Mumbai

Nimesulide 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablet in pain relief pharma franchise in Pune

Nimesulide 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablet in pharma suppliers in Delhi

Nimesulide 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablet in pharma export companies in Kolkata
Nimesulide 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /nimesulide-100-mg-pcm-325-mg-chlorzoxazone-250-mg-tablet

About the Product

Description


This combination tablet of Nimesulide, Paracetamol, and Chlorzoxazone is a triple-action formulation used for the effective management of musculoskeletal pain and inflammation. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain through selective COX-2 inhibition. Paracetamol provides antipyretic and mild analgesic effects, while Chlorzoxazone acts as a centrally acting muscle relaxant, reducing muscle spasms and associated discomfort. Together, these agents provide synergistic relief in painful musculoskeletal conditions such as sprains, strains, low back pain, and cervical spondylosis.

May cause mild gastrointestinal discomfort, nausea, drowsiness, dizziness, or skin rash in some individuals. Rarely, hepatotoxicity or allergic reactions may occur. Patients should report any unusual fatigue, yellowing of the skin, or persistent nausea.

Indicated for the treatment of acute musculoskeletal pain, lower back pain, muscle spasm-related pain, post-traumatic pain, and inflammation where both anti-inflammatory and muscle relaxant actions are required. Also beneficial in cases of sports injuries, orthopedic pain, and pain with muscle stiffness.

To be used under medical supervision only. Avoid concurrent use with other hepatotoxic drugs or alcohol. Not recommended in patients with liver dysfunction, peptic ulcer disease, or known hypersensitivity to any of the components. Use with caution in the elderly and those with renal impairment.

Store in a cool, dry place below 25°C. Protect from moisture and sunlight. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Nimesulide + Paracetamol + Chlorzoxazone Tablets in the PCD pharma franchise market?

Nimesulide + Paracetamol + Chlorzoxazone combination tablets have strong demand in the pain management and musculoskeletal segment, making them a fast-moving product for pharma distributors, wholesalers, and franchise partners. It is widely used for muscle pain, back pain, sprains, strains, and inflammatory conditions, ensuring consistent prescription-driven demand.

Why should medical distributors include this combination in their product range?

Medical distributors and agencies benefit from the high-volume demand for pain relief and orthopedic prescriptions. Nimesulide reduces inflammation and pain Paracetamol (PCM) provides additional pain and fever relief Chlorzoxazone relaxes muscle spasms and stiffness Commonly prescribed for back pain, neck pain, muscle spasm, and joint pain Widely used by orthopedic doctors and general physicians Strong demand in injury-related and lifestyle musculoskeletal pain cases This makes it a high-demand fast-moving pain management product.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from consistent pain-management prescription flow, strong orthopedic and general physician demand, repeat usage in acute and chronic pain cases, and stable year-round sales in the analgesic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete pain management product portfolio access to build a strong presence in the analgesic and musculoskeletal care market.